Hyperlipemia

Global cardiovascular mortality increased through 2022, with BP remaining the largest contributor to CVD worldwide, according to an almanac-style report published in the Journal of the American College of Cardiology.

ARLINGTON, Texas — In this Healio video exclusive, an expert breaks down a session on the significance of lipoprotein(a) at the American Society for Preventive Cardiology Congress on CVD Prevention.

WASHINGTON — Treatment with vupanorsen, a novel antisense oligonucleotide targeting hepatic ANGPTL3, achieved modest reductions in non-HDL at 24 weeks at all doses studied, according to results of the TRANSLATE-TIMI 70 trial.

Health care spending on CVD increased to $320 billion in 2016, with treatment for hypertension, hyperlipidemia and atrial fibrillation/flutter being the primary drivers, according to data published in Circulation.